RxDoctor Payments Data

Aras Emdadi, DO

Surgery · Riverside, CANPI 1477997336

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (58.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 87.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $10,129 and has fallen 76.0% since, to $2,434 in 2025.

$20,680in general payments, 2019–2025

Across 93 payments — averaging $222.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$18K
  • TELA Bio, Inc.$552
  • Aroa Biosurgery Incorporated$440
  • Integra Lifesciences Corporation$288
  • Vioptix Inc$251
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$181
  • plus $819 from 11 others

What the payments were for

  • Travel & lodging$4,26621%
  • Food & beverage$4,39921%
  • Education$12,00058%
  • Gifts$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,680 in reported general payments places this provider in the 85th percentile of 2,363 surgery providers in California.

See all surgery providers in California →

Medicare billing

Part B allowed, 2024
$84,191
Medicare patients
155
Services billed
337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl26$431
Neomycin Sulfate64$340
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl11$207
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$146
Metronidazole64$89

Paid to pharmacies, not to this prescriber.

Other surgery in Riverside

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →